A Suenaga

Author PubWeight™ 18.59‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Arg133Cys mutation of Notch3 in two unrelated Japanese families with CADASIL. Intern Med 2000 1.43
2 Nanoscale hydrophobic interaction and nanobubble nucleation. Phys Rev Lett 2004 1.06
3 Evidence for the presence of angiogenin in human follicular fluid and the up-regulation of its production by human chorionic gonadotropin and hypoxia. J Clin Endocrinol Metab 2000 0.95
4 Interaction mechanism between indoxyl sulfate, a typical uremic toxin bound to site II, and ligands bound to site I of human serum albumin. Pharm Res 2001 0.91
5 In vitro and in vivo properties of recombinant human serum albumin from Pichia pastoris purified by a method of short processing time. Pharm Res 2001 0.86
6 Characterization of a nonsense mutation in the ceruloplasmin gene resulting in diabetes and neurodegenerative disease. Hum Mol Genet 1996 0.85
7 A comparative study of the interaction of warfarin with human alpha 1-acid glycoprotein and human albumin. J Pharm Pharmacol 1987 0.82
8 Functional mapping against Escherichia coli for the broad-spectrum antimicrobial peptide, thanatin, based on an in vivo monitoring assay system. J Biochem 2000 0.81
9 Mutations of the notch3 gene in non-caucasian patients with suspected CADASIL syndrome. Dement Geriatr Cogn Disord 2001 0.80
10 Successful application of pentoxifylline in the treatment of HTLV-I associated myelopathy. J Neurol Sci 1997 0.80
11 Membrane fluidity changes of liposomes in response to various odorants. Complexity of membrane composition and variety of adsorption sites for odorants. Biophys J 1990 0.80
12 An immunological method for the detection of captopril-protein conjugate. Arch Toxicol 1998 0.78
13 Interactions of aldosterone antagonist diuretics with human serum proteins. Pharm Res 1997 0.78
14 Effects of fatty acids on serum binding between furosemide and valproic acid. Biol Pharm Bull 1998 0.78
15 Homozygosity and linkage disequilibrium mapping of autosomal recessive distal myopathy (Nonaka distal myopathy). J Hum Genet 2001 0.78
16 'Split tolerance' induction by intrathymic injection of acetylcholine receptor in a rat model of autoimmune myasthenia gravis; implications for the design of specific immunotherapies. Clin Exp Immunol 1995 0.77
17 [CADASIL: clinical analysis of CADASIL and CADASIL-like disorders in Japan]. Rinsho Shinkeigaku 2000 0.77
18 Hepatocyte growth factor concentrations are elevated in peritoneal fluid of women with endometriosis. Hum Reprod 1999 0.77
19 Mode of interaction of loop diuretics with human serum albumin and characterization of binding site. Pharm Res 1996 0.77
20 Antibodies to recombinant synaptotagmin and calcium channel subtypes in Lambert-Eaton myasthenic syndrome. J Neurol Sci 1995 0.77
21 Specificity of omega-conotoxin MVIIC-binding and -blocking calcium channel antibodies in Lambert-Eaton myasthenic syndrome. J Neurol 1999 0.77
22 Drug binding to alpha 1-acid glycoprotein studied by circular dichroism. Pharm Res 1989 0.76
23 Distribution and species composition of juvenile and adult scombropids (Teleostei, Scombropidae) in Japanese coastal waters. J Fish Biol 2010 0.75
24 Biopharmaceutical studies on pyridinolcarbamate. V. Effect of repeated administration of pyridinolcarbamate on the renal excretion of sulbenicillin in rabbits. Acta Pharm Suec 1985 0.75
25 Studies on synthetic sweetening agents. XVI. Metabolism of sodium cyclamate. 5. The metabolism of sodium cyclamate in rabbits and rats after prolonged administration of sodium cyclamate. Chem Pharm Bull (Tokyo) 1972 0.75
26 Studies on synthetic sweetening agents. XVII. Metabolism of sodium cyclamate. (6). Influences of neomycin and sulfaguanidine on metabolism of sodium cyclamate. Chem Pharm Bull (Tokyo) 1972 0.75
27 Determination of pyridinolcarbamate and its metabolites in rabbit plasma and urine by liquid chromatography. Acta Pharm Suec 1986 0.75
28 Arginine 485 of human serum albumin interacts with the benzophenone moiety of ketoprofen in the binding pocket of subdomain III A and III B. Pharmazie 2012 0.75
29 Evidence for the presence of keratinocyte growth factor (KGF) in human ovarian follicles. Endocr J 2001 0.75
30 Effect of repeated administration of pyridinolcarbamate on hypoglycemic activity after oral administration of acetohexamide in rabbits. Pharm Acta Helv 1986 0.75
31 [Differential effect of sodium bicarbonate on disposition of sulfadimethoxine and sulfisoxazole in rabbits]. Yakugaku Zasshi 1989 0.75
32 [Effects of polychlorinated biphenyls on regeneration of the peripheral nerve in rats]. Fukuoka Igaku Zasshi 1995 0.75
33 Seronegative myasthenia gravis associated with atonic urinary bladder and accommodative insufficiency. J Neurol Sci 1995 0.75
34 [Paraneoplastic neurologic syndromes. 2. Lambert-Eaton myasthenic syndrome. 2) Anti-calcium channel antibody and clinical features]. Nihon Naika Gakkai Zasshi 1998 0.75
35 [A case of hereditary ceruloplasmin deficiency with hemosiderosis]. Rinsho Shinkeigaku 1999 0.75
36 Evidence for the presence of hepatocyte growth factor expression in human ovarian follicles. Mol Hum Reprod 1999 0.75
37 Pentoxifylline treatment in HTLV-I-associated myelopathy. Intern Med 1995 0.75
38 [Anti-voltage-gated calcium channel antibodies in the Lambert-Eaton myasthenic syndrome]. Rinsho Shinkeigaku 1994 0.75
39 Interaction between salicylic acid and repeatedly administered pyridinolcarbamate in rabbits. Pharm Acta Helv 1987 0.75
40 Characterization of a binding site of UCN-01, a novel anticancer drug on alpha-acid glycoprotein. Biol Pharm Bull 2000 0.75
41 Differential effect of exogenous human chorionic gonadotrophin on progesterone production from normal or malfunctioning corpus luteum. Hum Reprod 1998 0.75
42 Studies on synthetic sweetening agents. XVIII. Metabolism of sodium cyclamate. (7). Dicyclohexylamine, a metabolite of sodium cyclamate in rabbits and rats. Chem Pharm Bull (Tokyo) 1983 0.75
43 Studies on synthetic sweetening agents. XV. Metabolism of sodium cyclamate. Influences of phenylbutaone, phenobarbital, and tolbutamide on metabolism of sodium cyclamate in rabbits. Chem Pharm Bull (Tokyo) 1972 0.75
44 [A family of hereditary neuropathy with liability to pressure palsies with a proband who developed right and left foot drop successively following the left radial nerve palsy]. J UOEH 1999 0.75
45 Stability of a cisplatin-chondroitin sulfate A complex in plasma and kidney in terms of protein binding. Biol Pharm Bull 2001 0.75
46 [Biopharmaceutical studies on pyridinolcarbamate. I. Effect of continuous pyridinolcarbamate administration on renal excretion of sulfonamides in rabbits (author's transl)]. Yakugaku Zasshi 1978 0.75
47 [Biopharmaceutical studies on pyridinolcarbamate. II. Isolation and identification of the urinary metabolites of pyridinolcarbamate in rabbits (author's transl)]. Yakugaku Zasshi 1978 0.75
48 [Biopharmaceutical studies on pyridinolcarbamate. III. Effect of continuous pyridinolcarbamate administration on renal excretion of phenolsulfonphthalein, p-aminohippuric acid, mannitol and inulin in rabbits (author's transl)]. Yakugaku Zasshi 1978 0.75
49 [Biopharmaceutical studies on pyridinolcarbamate. IV. Effect of continuous pyridinolcarbamate administration on hypoglycemic activity of tolbutamide and chlorpropamide in rabbits (author's transl)]. Yakugaku Zasshi 1979 0.75